Stockhub

Pharmaxis Ltd: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 08:3808:38, 19 August 2022 >Nick 1,172 bytes +1,172 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper..."
Retrieved from "https://stockhub.co/research/Pharmaxis_Ltd"